Zhuang, Qianyu
Bian, Yanyan
Wang, Wei
Jiang, Jingmei
Feng, Bin
Sun, Tiezheng
Lin, Jianhao
Zhang, Miaofeng
Yan, Shigui
Shen, Bin
Pei, Fuxing
Weng, Xisheng
Clinical trials referenced in this document:
Documents that mention this clinical trial
Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): a multicentre, double-blind, randomised, placebo-controlled trial (Results)
https://doi.org/10.1136/bmjopen-2019-030501
Efficacy and safety of
<i>P</i>
ostoperative
<i>I</i>
ntravenous
<i>P</i>
arecoxib sodium
<i>F</i>
ollowed by
<i>OR</i>
al
<i>CE</i>
lecoxib (PIPFORCE) post-total knee arthroplasty in patients with osteoarthritis: a study protocol for a multicentre, double-blind, parallel-group trial
https://doi.org/10.1136/bmjopen-2016-011732